- Home
- IRBT vs LYEL Comparison
IRBT vs LYEL Comparison
Compare IRBT & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- LYEL
- Stock Information
- Founded
- IRBT 1990
- LYEL 2018
- Country
- IRBT United States
- LYEL United States
- Employees
- IRBT N/A
- LYEL N/A
- Industry
- IRBT Consumer Electronics/Appliances
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- IRBT Consumer Discretionary
- LYEL Health Care
- Exchange
- IRBT Nasdaq
- LYEL Nasdaq
- Market Cap
- IRBT 267.4M
- LYEL 263.9M
- IPO Year
- IRBT N/A
- LYEL 2021
- Fundamental
- Price
- IRBT $7.43
- LYEL $0.62
- Analyst Decision
- IRBT Hold
- LYEL Sell
- Analyst Count
- IRBT 2
- LYEL 2
- Target Price
- IRBT $13.00
- LYEL $1.00
- AVG Volume (30 Days)
- IRBT 1.1M
- LYEL 1.5M
- Earning Date
- IRBT 11-06-2024
- LYEL 11-07-2024
- Dividend Yield
- IRBT N/A
- LYEL N/A
- EPS Growth
- IRBT N/A
- LYEL N/A
- EPS
- IRBT N/A
- LYEL N/A
- Revenue
- IRBT $817,355,000.00
- LYEL $63,000.00
- Revenue This Year
- IRBT N/A
- LYEL N/A
- Revenue Next Year
- IRBT N/A
- LYEL N/A
- P/E Ratio
- IRBT N/A
- LYEL N/A
- Revenue Growth
- IRBT N/A
- LYEL N/A
- 52 Week Low
- IRBT $5.83
- LYEL $0.58
- 52 Week High
- IRBT $39.17
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- IRBT 41.30
- LYEL 27.76
- Support Level
- IRBT $8.07
- LYEL $0.58
- Resistance Level
- IRBT $9.33
- LYEL $0.95
- Average True Range (ATR)
- IRBT 0.66
- LYEL 0.07
- MACD
- IRBT -0.13
- LYEL -0.02
- Stochastic Oscillator
- IRBT 5.63
- LYEL 6.48
About IRBT iRobot Corporation
iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.